A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile K Suresh, MKC Mannava, A Nangia Rsc Advances 4 (102), 58357-58361, 2014 | 82 | 2014 |
Soluble salts and cocrystals of clotrimazole S Mittapalli, MKC Mannava, UBR Khandavilli, S Allu, A Nangia Crystal Growth & Design 15 (5), 2493-2504, 2015 | 71 | 2015 |
Entacapone: Improving aqueous solubility, diffusion permeability, and cocrystal stability with theophylline MK Bommaka, MKC Mannava, K Suresh, A Gunnam, A Nangia Crystal Growth & Design 18 (10), 6061-6069, 2018 | 67 | 2018 |
Enhanced bioavailability in the oxalate salt of the anti-tuberculosis drug ethionamide MKC Mannava, K Suresh, A Nangia Crystal Growth & Design 16 (3), 1591-1598, 2016 | 55 | 2016 |
Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics K Suresh, MKC Mannava, A Nangia Chemical Communications 52 (22), 4223-4226, 2016 | 50 | 2016 |
Improved stability of tuberculosis drug fixed-dose combination using isoniazid-caffeic acid and vanillic acid cocrystal S Battini, MKC Mannava, A Nangia Journal of Pharmaceutical Sciences 107 (6), 1667-1679, 2018 | 49 | 2018 |
Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation MKC Mannava, A Gunnam, A Lodagekar, NR Shastri, AK Nangia, ... CrystEngComm 23 (1), 227-237, 2021 | 47 | 2021 |
Improving the dissolution rate of the anticancer drug dabrafenib SK Rai, A Gunnam, MKC Mannava, AK Nangia Crystal Growth & Design 20 (2), 1035-1046, 2020 | 41 | 2020 |
Curcumin-artemisinin coamorphous solid: Xenograft model preclinical study MKC Mannava, K Suresh, M Kumar Bommaka, D Bhavani Konga, ... Pharmaceutics 10 (1), 7, 2018 | 36 | 2018 |
Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation A Lodagekar, RB Chavan, MKC Mannava, B Yadav, N Chella, AK Nangia, ... European Journal of Pharmaceutical Sciences 139, 105048, 2019 | 30 | 2019 |
Cocrystals, salts, and supramolecular gels of nonsteroidal anti-inflammatory drug niflumic acid S Mittapalli, MKC Mannava, R Sahoo, A Nangia Crystal Growth & Design 19 (1), 219-230, 2018 | 29 | 2018 |
Role of hydrogen bonding in cocrystals and coamorphous solids: indapamide as a case study S Allu, K Suresh, G Bolla, MKC Mannava, A Nangia CrystEngComm 21 (13), 2043-2048, 2019 | 26 | 2019 |
Naftopidil molecular salts with improved dissolution and permeation MKC Mannava, R Dandela, S Tothadi, KA Solomon, AK Nangia Crystal Growth & Design 20 (5), 3064-3076, 2020 | 24 | 2020 |
Quantification of niclosamide polymorphic forms–A comparative study by Raman, NIR and MIR using chemometric techniques V Bhavana, RB Chavan, MKC Mannava, A Nangia, NR Shastri Talanta 199, 679-688, 2019 | 23 | 2019 |
Diffusion and Flux Improvement of Drugs through Complexation MKC Mannava, A Garai, AK Nangia Molecular Pharmaceutics 20 (5), 2293-2316, 2023 | 18 | 2023 |
Fluorobenzoic acid coformers to improve the solubility and permeability of the BCS class IV drug naftopidil MKC Mannava, MK Bommaka, R Dandela, KA Solomon, AK Nangia Chemical Communications 58 (37), 5582-5585, 2022 | 18 | 2022 |
Entacapone polymorphs: crystal structures, dissolution, permeability, and stability MK Bommaka, MK Chaitanya Mannava, SK Rai, K Suresh, AK Nangia Crystal Growth & Design 21 (10), 5573-5585, 2021 | 16 | 2021 |
Preclinical bioavailability–bioequivalence and toxico-kinetic profile of stable succinc acid cocrystal of temozolomide E Sravani, MKC Mannava, D Kaur, BR Annapurna, RA Khan, K Suresh, ... Current Science, 1097-1106, 2015 | 11 | 2015 |
Solubility and permeability enhancement of BCS class IV drug ribociclib through cocrystallization MKC Mannava, A Garai, MK Bommaka, KA Solomon, AK Nangia CrystEngComm 24 (45), 7915-7923, 2022 | 7 | 2022 |
The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation T Dubey, SK Sonawane, MKC Mannava, AK Nangia, M Chandrashekar, ... Colloids and Surfaces B: Biointerfaces 221, 112970, 2023 | 3 | 2023 |